Market Place
Sourcing Support
Guided Therapeutics Study Shows Urgent Clinical Need For Luviva
17 Dec 2025 //
BUSINESSWIRE
Guided Therapeutics Gets $88K Payment In Third Installment
11 Dec 2025 //
BUSINESSWIRE
Guided Therapeutics Signs $200K Deal With Yuanshuo Medical
19 Nov 2025 //
BUSINESSWIRE
Guided Gets $70K From China Partner for Cancer Screening
19 Aug 2025 //
BUSINESSWIRE
Guided Therapeutics Updates on US FDA Clinical Trial Completion
13 Aug 2025 //
BUSINESSWIRE
Guided Therapeutics Ships to Hangzhou Dongye Medical in China
02 Jul 2025 //
BUSINESSWIRE
Guided Therapeutics gets $100,000 from SMI for LuViva in China
27 May 2025 //
BUSINESSWIRE
Guided Therapeutics Files NMPA Application For LuViva In China
22 Oct 2024 //
BUSINESSWIRE
Guided Therapeutics Announces Start of Chinese Clinical Trial for LuViva
17 Nov 2021 //
BUSINESSWIRE
Guided Therapeutics Receives News from Chinese State FDA on LuViva
20 Jul 2021 //
BIOSPACE
Guided Therapeutics Raises US $1.1 Million in New Preferred Stock Offering
16 Feb 2021 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.